Patient, Registries, Evidence, Value, Evidence Europe

How can patient registries add value to evidence based decision making?

At Evidence EU 2014, Dr. Päivi Hämäläinen, Director of Department of Information, National Institute of Health and Welfare, Finland, gave a presentation “How can patient registries add value to evidence based decision making?” Dr. Päivi Hämäläinen’s presentation depicts her theoretical vision: data is created during patient visits to care and can be secondarily used for research, planning and decision making. Download and …

Disease, Value, Registries, Decision making, Evidence, Evidence Europe

How Can Disease Registries Add Value to Evidence Based Decision Making?

At Evidence EU 2014, Steve Cunningham Consultant & Honorary Reader in Paediatric Respiratory Medicine, NHS, gave a presentation on “How Can Disease Registries Add Value to Evidence Based Decision Making?” Download and learn:  Case Identifier Registry Detailed Case Registry Large Disease Registry Current Definitions of Evidence Quality Evidence Quality -GRADE System Detailed Observational Data Download presentation Found this interesting? Join us at …

value, assessment

From promise to reality: how is real world evidence shaping the future of healthcare?

At Evidence EU  2014, David Haslam, Chairman NICE gave a presentation on “From promise to reality: how is real world evidence shaping the future of healthcare?” This presentation explores NICE’s role in improving outcomes for people as well as focusing on challenges (uptake, implementation and pushy patients) and value-based assessment. Download and learn: The multi morbidity challenge Value Based Assessment …

patient, outcomes

How can patient reported outcomes generate evidence to validate health claims?

At Evidence EU 2014, Tara Symonds , Senior Director, Pfizer, gave a presentation on  “How can patient reported outcomes generate evidence to validate health claims?” Symonds’ presentation reveals her belief that PRO data is increasingly seen as important by payers for validating health claims from a patient perspective. She also mentions both the EU HTA community and US Federal government calling for …

observational research, payer, development, value, outcomes research, evidence europe

How can observational research be used to improve value development?

  At Evidence EU 2014, Clément François, Global Outcomes Research, Lundbeck gave a presentation on “Meeting payers’ needs: How can observational research be used to improve value development?” This presentation discusses the use of observational data through the different phases of development, as well as the different data sources for different objectives-from small dataset to large automated health care database. …